141 related articles for article (PubMed ID: 17491213)
21. Left ventricular systolic function following alcohol septal ablation for symptomatic hypertrophic cardiomyopathy.
Moss TJ; Krantz MJ; Zipse MM; Quaife RA; Sauer WH; Messenger JC; Groves BM; Salcedo EE; Schuller JL
Am J Cardiol; 2014 Apr; 113(8):1401-4. PubMed ID: 24576545
[TBL] [Abstract][Full Text] [Related]
22. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
[TBL] [Abstract][Full Text] [Related]
23. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
[TBL] [Abstract][Full Text] [Related]
26. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years.
Veselka J; Tomašov P; Zemánek D
Can J Cardiol; 2011; 27(6):763-7. PubMed ID: 22000583
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Tsuchikane E; Takeda Y; Kobayashi T; Yachiku K; Nasu K; Kobayashi Y; Matsumoto H; Awata N
Circ J; 2003 Sep; 67(9):763-7. PubMed ID: 12939552
[TBL] [Abstract][Full Text] [Related]
29. Biventricular reverse remodeling after successful alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Chen YZ; Qiao SB; Hu FH; Yuan JS; Yang WX; Cui JG; Zhang Y; Zhou Y; Zhang CL
Am J Cardiol; 2015 Feb; 115(4):493-8. PubMed ID: 25541323
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation.
Kwon DH; Kapadia SR; Tuzcu EM; Halley CM; Gorodeski EZ; Curtin RJ; Thamilarasan M; Smedira NG; Lytle BW; Lever HM; Desai MY
JACC Cardiovasc Interv; 2008 Aug; 1(4):432-8. PubMed ID: 19463341
[TBL] [Abstract][Full Text] [Related]
31. Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum.
Veselka J; Tomasov P; Zemánek D
J Invasive Cardiol; 2012 Dec; 24(12):636-40. PubMed ID: 23220977
[TBL] [Abstract][Full Text] [Related]
32. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
Balt JC; Wijffels MC; Boersma LV; Wever EF; ten Berg JM
Heart; 2014 Dec; 100(23):1865-70. PubMed ID: 25073885
[TBL] [Abstract][Full Text] [Related]
33. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002).
Fernandes VL; Nagueh SF; Wang W; Roberts R; Spencer WH
Clin Cardiol; 2005 Mar; 28(3):124-30. PubMed ID: 15813618
[TBL] [Abstract][Full Text] [Related]
34. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.
Wojtarowicz A; Kornacewicz-Jach Z
Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458
[TBL] [Abstract][Full Text] [Related]
35. Intracoronary electrocardiogram during alcohol septal ablation for hypertrophic obstructive cardiomyopathy predicts myocardial injury size.
Meng J; Qu X; Huang H; Zhang S; Zhao W; He G; Song Z; Hu H
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):75-80. PubMed ID: 26473435
[TBL] [Abstract][Full Text] [Related]
36. Age-related hemodynamic and morphologic differences in patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Duchonová R; Pálenícková J; Zemánek D; Sváb P; Hájek P; Maly M; Blásko P; Tesar D; Cervinka P
Circ J; 2006 Jul; 70(7):880-4. PubMed ID: 16799242
[TBL] [Abstract][Full Text] [Related]
37. Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic Cardiomyopathy.
Jensen MK; Jacobsson L; Almaas V; van Buuren F; Hansen PR; Hansen TF; Aakhus S; Eriksson MJ; Bundgaard H; Faber L
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27217377
[TBL] [Abstract][Full Text] [Related]
38. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry.
Kuhn H; Seggewiss H; Gietzen FH; Boekstegers P; Neuhaus L; Seipel L
Z Kardiol; 2004 Jan; 93(1):23-31. PubMed ID: 14740238
[TBL] [Abstract][Full Text] [Related]
39. Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study.
Veselka J; Lawrenz T; Stellbrink C; Zemanek D; Branny M; Januska J; Sitar J; Dimitrow P; Krejci J; Dabrowski M; Mizera S; Bartel T; Kuhn H
Catheter Cardiovasc Interv; 2014 Jul; 84(1):101-7. PubMed ID: 24285605
[TBL] [Abstract][Full Text] [Related]
40. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
van Dockum WG; Beek AM; ten Cate FJ; ten Berg JM; Bondarenko O; Götte MJ; Twisk JW; Hofman MB; Visser CA; van Rossum AC
Circulation; 2005 May; 111(19):2503-8. PubMed ID: 15867172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
